Non-invasive molecular immune profiling from the site of disease.
JORA DIPS™ transforms a simple skin swab into protein-level immune insights that can support disease classification, treatment selection, and precision dermatology research.
Beyond sample collection and molecular profiling, JORA has built proprietary AI models that translate protein and immune signatures into clinically meaningful insights. These models are being validated for two core use cases: assisting high-accuracy disease diagnosis and supporting personalized treatment selection across inflammatory skin diseases.
JORA has developed proprietary AI models that interpret lesion-site protein and immune signatures to help distinguish clinically overlapping inflammatory skin diseases. Performance validation demonstrates the potential to support more objective, consistent, and highly accurate diagnosis.
JORA's AI models integrate protein biomarkers, immune pathway activity, and molecular disease patterns to estimate treatment response across inflammatory skin diseases. By identifying patient-specific molecular signatures, the models are designed to support selection of the therapy most likely to deliver clinical benefit. Validation studies demonstrate strong predictive performance across treatment-selection tasks.
Discover the study describing the development and validation of JORA’s non-invasive molecular profiling approach for inflammatory skin disease.
